PetMed Express, Inc. (NASDAQ:PETS) Director Gian Fulgoni sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $44.38, for a total transaction of $887,600.00. Following the completion of the sale, the director now owns 55,900 shares of the company’s stock, valued at $2,480,842. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Shares of PetMed Express, Inc. (NASDAQ PETS) traded up $1.26 during midday trading on Friday, reaching $52.94. 675,148 shares of the company’s stock traded hands, compared to its average volume of 472,077. PetMed Express, Inc. has a 1-year low of $19.21 and a 1-year high of $53.32. The company has a market cap of $1,064.83, a price-to-earnings ratio of 35.53, a PEG ratio of 3.07 and a beta of 1.12.
PetMed Express (NASDAQ:PETS) last released its earnings results on Monday, October 23rd. The company reported $0.43 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.13. The firm had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The company’s revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.24 EPS. analysts predict that PetMed Express, Inc. will post 1.68 earnings per share for the current fiscal year.
Several large investors have recently added to or reduced their stakes in PETS. Acrospire Investment Management LLC purchased a new stake in shares of PetMed Express in the 2nd quarter worth about $110,000. Pinebridge Investments L.P. grew its position in shares of PetMed Express by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock worth $110,000 after buying an additional 27 shares during the period. Sei Investments Co. grew its position in shares of PetMed Express by 50,142.9% in the 3rd quarter. Sei Investments Co. now owns 3,517 shares of the company’s stock worth $117,000 after buying an additional 3,510 shares during the period. Thompson Siegel & Walmsley LLC purchased a new stake in shares of PetMed Express in the 3rd quarter worth about $149,000. Finally, Fred Alger Management Inc. purchased a new stake in PetMed Express during the 2nd quarter valued at about $162,000. 99.88% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts recently commented on PETS shares. Credit Suisse Group reiterated an “underperform” rating and set a $19.00 price target on shares of PetMed Express in a report on Monday, October 2nd. Noble Financial reiterated a “hold” rating on shares of PetMed Express in a report on Friday, October 27th. ValuEngine lowered shares of PetMed Express from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Zacks Investment Research upgraded shares of PetMed Express from a “sell” rating to a “hold” rating and set a $50.00 price target for the company in a report on Friday, October 20th. Finally, Northcoast Research set a $58.00 price target on shares of PetMed Express and gave the company a “buy” rating in a report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $42.80.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.